Women's Health

On the second anniversary of the overturning of Roe v Wade, check out recent coverage on abortion and contraceptive access.

Four posters presented at ENDO 2024 explored the interplay of hormones and other factors in postmenopausal women.

Three posters presented at ENDO 2024 focused on women’s health.

As Women’s Health Week comes to a close, check out some of our recent women’s health coverage. Dive deep into everything from skin care myths to reproductive care access.

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.

This week, a divided America watched as the Supreme Court heard oral arguments regarding whether to reinstate restrictions on accessing mifepristone, an essential drug used in medication abortion.

Access to counseling and education were strong predictors of being dispensed contraceptives.

Supreme Court decisions and state-level legislation have made abortion access in some states more complicated than ever before.

These OTC products are recommended to address a variety of symptoms associated with women's health issues.

See what's trending in pharmacy with a preview the Drug Topics March issue.

Telehealth mitigates barriers like stigma, fear, and legal concerns associated with receiving opioid use disorder (OUD) care by offering a convenient and discreet treatment option.

N-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.

Study findings clarifying what to expect regarding the menstrual cycle after COVID-19 vaccination could help address low vaccine uptake.

The decision comes a year after a group of conservative attorneys generals threatened the chains with legal action.

A new study found that opioid morphine milligram equivalents dose prescribed in the 60 days prior to delivery date was significantly associated with a higher likelihood of spontaneous preterm birth.

Interventions have been implemented to raise the number of applications to OBGYN programs, including allowing applicants to submit up to 18 signals relating to their preferred programs.

Cortisol is a stress regulating hormone with associated adverse health outcomes for prolonged exposure including diabetes and high blood pressure.

Despite previously suggested benchmarks, investigators found that spending less time-in-range (TIR) can still improve maternal and perinatal outcomes among pregnant patients with type 1 diabetes (T1D).

Investigators noted that findings data should inform public health policy and reassure providers and expectant mothers.

The Affordable Care Act mandates that contraceptives must be covered by health plans and insurers without cost-sharing.

Findings from the current study lend scientific credence to the idea that making informed dietary choices can help promote favorable health outcomes.

Results from a meta-analysis demonstrated that magnesium supplementation was able to decrease fasting glucose levels and improve insulin resistance.

Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.

A new report from the CDC demonstrated a decrease in cigarette smoking across all race and ethnic groups from 2016 to 2022, illustrating a promising trend with potential public health benefits.

Lupin gained FDA approval for varenicline tablets (0.5 mg and 1 mg) and launched its already-approved Turqoz (norgestrel and ethinyl estradiol) tablets USP, 0.3 mg/0.03 mg earlier this month.

Immunizations against influenza, COVID-19, and RSV are lower than they were this time last year, and hospitalizations have increased across all age groups.